Rheumatology and Immunology

Telephone: 020-89169090 Address: Building 2, 2nd floor Department Profile Rheumatology is a rapidly developing comprehensive emerging discipline. The diseases involved include ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, gout, reactive arthritis, psoriatic arthritis, dermatomyositis, scleroderma, Behçet's disease, Sjögren's syndrome, adult-onset Still's disease, and more than 100 diseases in total that primarily affect bones, joints, muscles and other connective tissues, as well as multiple systems throughout the body. The Department of Rheumatology and Immunology of Guangdong Second People's Hospital is a key discipline of our hospital. The discipline leader, Professor Li Tianwang, holds a doctorate in internal medicine, is a master's supervisor, and was a visiting scholar at Harvard University. In 2018, he received the inaugural “Guangdong Physician Award” and was selected among the top 10 of the second “Guangdong Good Doctors”; during 2014～2018, he received the title of “Good Doctor of the Year” from Good Doctor Online in four editions; in 2016, he was named a “Yangcheng Good Doctor” by Family Doctor Online; in the 2017 “Lingnan Famous Doctors” list of the Guangdong Family Doctors Association, he ranked first among famous specialists in rheumatology. He has been engaged in the clinical practice, teaching and research of rheumatology for more than 20 years and has extensive clinical and research experience in rheumatic diseases. The specialty currently has 2 professors/chief physicians, 1 associate chief physician, 3 attending physicians, 8 resident physicians, 1 supervising technologist and 15 nursing personnel at various levels, including 3 holders of doctorates and 10 holders of master's degrees; in addition, the specialty has engaged 3 renowned foreign professors to guide its clinical and research work. The specialty has expert and specialty outpatient clinics, an independent specialty inpatient ward and a rheumatology and immunology laboratory. At present, both the number of beds in the ward and the number of patients treated are among the highest in Guangdong, and the admitted patients come from cities throughout China and from countries in Southeast Asia. The specialty's current distinctive services mainly include: (1) early diagnosis and standardized treatment of seronegative spondyloarthritis, such as ankylosing spondylitis, psoriatic arthritis and reactive arthritis; (2) standardized management and treatment of gout, helping a large number of gout patients achieve satisfactory therapeutic results, with particularly extensive experience in managing ulcerated wounds caused by refractory tophi; (3) fine-needle puncture synovial biopsy of joints and ultrasound examinations of the osteoarticular system to improve the rate of early diagnosis of joint diseases; (4) standardized treatment and follow-up of patients with diffuse connective tissue diseases, including systemic lupus erythematosus, dermatomyositis, Sjögren's syndrome and rheumatoid arthritis, to prevent recurrence and improve patient prognosis; (5) ultrasound-guided local injection treatment at sites including the hip joint and Achilles tendon enthesis for patients with ankylosing spondylitis accompanied by hip involvement or refractory enthesitis, achieving satisfactory results; (6) biological-agent treatment of ankylosing spondylitis and rheumatoid arthritis, enabling patients to achieve rapid relief and greatly improving their prognosis; (7) the specialty is qualified to conduct clinical drug trials as certified by the National Medical Products Administration and routinely conducts clinical trials of new drugs; (8) to meet the medical needs of the many patients, in addition to providing all-day outpatient services from Monday to Friday, the specialty also provides expert or specialty outpatient clinics every Saturday and Sunday morning. Rheumatology and Immunology Department team with first-rate technical services Professor rounds in the Department of Rheumatology and Immunology Professor David Hunter, visiting professor of our department, examining a patient Department professional study Our department has independent specialty outpatient, inpatient and laboratory facilities. The specialty outpatient clinic is located in the Internal Medicine consultation rooms on the 3rd floor of Building 1. To meet patients' needs, outpatient services are provided 7 days a week. The specialty has 44 authorized beds and provides a range of distinctive medical technologies, including biological-agent treatment of ankylosing spondylitis and rheumatoid arthritis, joint aspiration and intra-articular medication injection for the treatment of arthritis, ultrasound examination of the osteoarticular system, ultrasound-guided local injection treatment at sites including the hip joint and Achilles tendon enthesis for patients with ankylosing spondylitis accompanied by hip involvement or refractory enthesitis, fine-needle puncture synovial biopsy, and training in functional exercises for patients with rheumatic diseases. The specialty has a dedicated rheumatology and immunology laboratory that performs a variety of autoantibody tests, including the ANA and ENA antibody profiles, as well as genetic tests for HLA-B27, HLA-B5801 and HLA-B1502, providing important reference information for the diagnosis of rheumatic and immune diseases. In addition, our hospital can perform a variety of examinations, including magnetic resonance imaging (MRI), bone mineral density testing and musculoskeletal ultrasound, to assist in the diagnosis of rheumatic diseases. Led by Head Nurse Pan Xia, the nursing team has more than 10 years of experience in critical care nursing and can provide high-quality nursing services for patients with rheumatic diseases, with particular expertise in the nursing care of patients with severe rheumatic diseases. While diagnosing and treating diseases, the department's medical and nursing personnel place particular emphasis on humanistic care and have established good and harmonious doctor-patient relationships with patients. To better follow up and manage patients, our department has created multiple WeChat groups for patients; every year, it organizes more than 20 themed patient meetings and free medical consultation activities, and has created 6 public WeChat accounts, including “Guangdong Second People's Hospital Department of Rheumatology and Immunology” and “Rheumatology Department of the Provincial Second Medical Hospital”, providing convenient services such as registration, payment and laboratory-result inquiries, and disseminating knowledge on the prevention and treatment of rheumatic diseases. Since its establishment, the department has provided high-quality diagnostic and treatment services to tens of thousands of patients inside and outside the province, has received many silk banners and letters of thanks, and has earned patients' recognition and praise. Clean and comfortable inpatient wards A laboratory equipped with advanced facilities Our department places great emphasis on basic research in rheumatic and immune diseases. Department personnel have led or participated in more than 10 research projects, including projects funded by the National Natural Science Foundation of China, the Guangdong Provincial Natural Science Foundation and the Guangdong Science and Technology Plan. They have published more than 40 rheumatology research papers in domestic and international journals, including Rheumatology, Clinical and Experimental Rheumatology, Rheumatol International, ChineseMedical Journal, Chinese Journal of Rheumatology and Chinese Medical Journal, and have co-edited 2 monographs on rheumatic diseases. At the same time, the discipline leader serves as a reviewer for the Guangdong Provincial Natural Science Foundation, Deputy Editor-in-Chief of Clinical Medical Engineering, an editorial board member of China Medical Herald, and a reviewing expert for Chinese Medical Journal and Chinese Medical Journal (English Edition). In the future, all medical and nursing personnel of the department will continue to uphold the work style of “diligence, pragmatism and enterprise”, further improve their professional standards, continuously strengthen their clinical diagnostic and treatment capabilities, and continue to provide high-quality medical services to more patients with rheumatic diseases. Rheumatology and Immunology Department outpatient clinic: Building 1, 3rd floor Rheumatology and Immunology Department ward: Building 2, 2nd floor Department telephone: 020-89169090 、020-89169091 The department has 6 public WeChat accounts: Guangdong Second People's Hospital Department of Rheumatology and Immunology, Rheumatology Department of the Provincial Second Medical Hospital, Ankylosing Spondylitis Online, South China Gout Online, Lupus Online, Rheumatoid Arthritis Online Nationally first-class physician team: Li Tianwang, male, Director of the Department of Rheumatology and Immunology, chief physician, medical doctorate, master's supervisor, visiting scholar at Massachusetts General Hospital affiliated with Harvard Medical School, member of the 9th Youth Committee of the Rheumatology Branch of the Chinese Medical Association, standing committee member of the Internal Medicine Branch of the Guangdong Medical Association, member of the Rheumatology Branch of the Guangdong Medical Association, member of the Rheumatology Branch of the Guangdong Medical Doctor Association, standing committee member of the Clinical Department Directors Branch of the Guangdong Hospital Association, standing committee member of the Clinical Immunology Branch of the Guangdong Society for Immunology, standing committee member of the Rheumatology and Immunology and Rehabilitation Professional Committee of the Guangdong Health Management Association, standing committee member of the Guangdong Association of Integrated Traditional Chinese and Western Medicine Rheumatology, and volunteer physician for the Fengshi Jiayuan website (http://www.as-sky.com). After graduating with a bachelor's degree from Sun Yat-sen Medical University in 1995, he began work in the clinical practice, teaching and research of rheumatology. In 2002 and 2009, he respectively obtained master's and doctoral degrees in internal medicine from Sun Yat-sen University. His main research direction is the basic and clinical research of ankylosing spondylitis. He has led or participated in more than 10 national-, provincial-, bureau- and department-level research projects, published more than 40 research papers, including 6 SCI-indexed papers as first or corresponding author, and co-edited 2 monographs on rheumatic diseases. He has been engaged in the clinical practice of rheumatology for more than 20 years and has extensive clinical experience in rheumatic diseases and a substantial patient base. He specializes in the diagnosis and treatment of rheumatic and immune diseases, including ankylosing spondylitis, psoriatic arthritis and Reiter syndrome and other seronegative spondyloarthritis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, dermatomyositis, polymyositis, Behçet's disease, adult-onset Still's disease, gout, osteoarthritis, scleroderma, systemic vasculitis and osteoporosis. Ding Changhai, male, guest professor of our department, professor and doctoral supervisor at the University of Tasmania, deputy director of the Menzies Institute for Medical Research, honorary professor at the University of Sydney, adjunct professor at Monash University, distinguished professor at Southern Medical University, guest professor at Anhui Medical University and director of its Institute of Arthritis Research. He graduated from the Department of Clinical Medicine of Anhui Medical University in 1990 and obtained a Doctor of Medicine degree from the Institute of Clinical Pharmacology of Anhui Medical University in 1999. From 2001.1-2003.12, he conducted postdoctoral research in clinical epidemiology at the University of Tasmania. He subsequently worked at the Menzies Institute for Medical Research of the University of Tasmania and remains there to the present. During more than 20 years of work in clinical pharmacology and epidemiology, he has undertaken more than 10 research projects, including General Program projects of the National Natural Science Foundation of China, the Australian Government ARC Future Fellowship, and General Program projects of the Australian Government National Health and Medical Research Council (NHMRC). He has extensive experience in clinical epidemiological research and clinical pharmacological trials in osteoarthritis. He has published more than 170 SCI papers in journals including JAMA, JAMA Internal Medicine, Annals of the Rheumatic Diseases, Arthritis & Rheumatology and Journal of the American College of Cardiology, with an average impact factor of 5 points; more than 40 have an impact factor above 5.0, nearly 20 have an impact factor above 10.0, and his papers have been cited more than 4,000 times. His H-index is 35. David Hunter, male, guest professor of our department, professor at the University of Sydney Medical School, doctoral supervisor, Dean in charge of academic affairs at Harvard School of Public Health, and an expert at the Royal North Shore and Northern Sydney Bone and Sports Medicine Centre. His main research direction is clinical translational research on rheumatic diseases such as osteoarthritis. He was selected by Expertscape.com as one of the world's foremost osteoarthritis experts. He is a member of the Australian Medical Association, the Australian Rheumatology Association, the American College of Rheumatology and the International Osteoarthritis Research Institute. He has received multiple grants from the National Health and Medical Research Council (NHMRC), the American Red Cross (ARC), the National Institutes of Health (NIH), the Arthritis Foundation and the American College of Rheumatology. He is the classification editor for Osteoarthritis at Up To Date. He is a member of the editorial boards of Arthritis and Rheumatology, Arthritis Care amd Research and Osteoarthritis and Cartilage, and participates in grant reviews for the ARC, NIH and Arthritis Foundation. He has published more than 350 papers in international journals and completed the monograph Public Self-Management Strategies. Deng Weiming, male, associate chief physician, master's degree in medicine, member of the Rheumatology and Immunology Professional Committee of the Guangdong Association of Integrated Traditional Chinese and Western Medicine, member of the Rheumatology and Immunology and Rehabilitation Professional Committee of the Guangdong Rehabilitation Medicine Association, and council member of the Immunology Professional Committee of the World Federation of Chinese Medicine Societies. He graduated with a bachelor's degree in clinical medicine from Sun Yat-sen Medical University, obtained a master's degree in internal medicine from Sun Yat-sen University in 2010, has published more than 10 professional papers in recent years, and has led 2 provincial- and municipal-level research projects. He has been engaged in the clinical practice of rheumatology for more than 10 years and specializes in the diagnosis and treatment of rheumatic and immune diseases, including ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, gout, osteoarthritis, scleroderma and dermatomyositis. Zeng Zhaoqiu, male, associate chief physician, master's degree in medicine, graduated with a bachelor's degree in clinical medicine from Sun Yat-sen Medical University, has published 5 professional papers in recent years, and has participated in 2 provincial-level research projects. He has been engaged in rheumatology-related clinical work for more than 10 years and specializes in the diagnosis and treatment of rheumatic and immune diseases, including systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, ankylosing spondylitis, scleroderma and dermatomyositis. Zheng Shaoling, female, attending physician, master's degree in medicine, professional committee member of the Pediatric Allergy, Immunology and Rheumatology Branch of the Asia-Pacific Association of Medical Biology and Immunology, committee member of the Guangdong Precision Medicine Application Sub-association, and committee member of the Rheumatology Professional Committee of the Guangdong Association of Integrated Traditional Chinese and Western Medicine. She has been engaged in clinical work for more than 10 years and specializes in the diagnosis and treatment of common rheumatic diseases, including pediatric rheumatic diseases, Behçet's disease, ankylosing spondylitis, rheumatoid arthritis, gout, systemic lupus erythematosus and dermatomyositis. Huang Zhixiang, male, attending physician, master's degree in medicine, graduated from Sun Yat-sen University and obtained a master's degree, participated in 7 research projects, and has published more than 10 papers. He specializes in the diagnosis and treatment of common rheumatic diseases, including ankylosing spondylitis and other spondyloarthritis, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, Sjögren's syndrome, dermatomyositis, polymyositis, scleroderma and primary vasculitis, and is proficient in musculoskeletal ultrasound and joint aspiration techniques. Guo Xin, female, master's degree in medicine, attending physician, graduated from Sun Yat-sen University and obtained a master's degree, participated in 2 provincial-level research projects, and has published 2 papers in domestic core journals. She specializes in the diagnosis and treatment of common rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus and osteoarthritis. Huang Zhengping, male, resident physician, graduated from Sun Yat-sen Medical School of Sun Yat-sen University and holds a master's degree in medicine. He is engaged in the clinical and research work of rheumatic and immune diseases. He is familiar with the diagnosis and treatment of rheumatic diseases, including ankylosing spondylitis and other spondyloarthritis, gout, rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis and rheumatic and immune recurrent miscarriage. He has participated in multiple national, provincial and hospital medical research funds and has published several articles. He previously received the Best Abstract Award at the annual congress of the European Alliance of Associations for Rheumatology (Eular). Huang Yukai, male, resident physician, medical doctorate, graduated from Southern Medical University. He is familiar with and proficient in the diagnosis and treatment of diseases including ankylosing spondylitis, rheumatoid arthritis and osteoarthritis. He has led and participated in multiple research projects at or above the provincial level and has published multiple articles in domestic and international journals. Huang Xuechan, female, medical doctorate, resident physician, graduated from the Clinical Medicine—Rheumatology and Immunology program of Southern Medical University. She has been engaged in the clinical, research and public science education work of rheumatology for 6 years, has published 1 paper in an international SCI journal, has led 1 in-hospital youth-fund research project, and has participated in multiple National Natural Science Foundation of China and provincial research projects. She is familiar with the diagnosis and treatment of various rheumatic diseases, including ankylosing spondylitis, rheumatoid arthritis, systemic lupus erythematosus, gout, osteoarthritis, myositis and Sjögren's syndrome. Yao Xiaoyan, female, resident physician, master's degree in medicine, graduated from Peking University Health Science Center and systematically completed the first phase of resident physician training at Peking University Health Science Center. She is familiar with the diagnosis and treatment of diseases in internal medicine and the Department of Rheumatology and Immunology, such as gout, ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, scleroderma, vasculitis and dermatomyositis, as well as the diagnosis and differential diagnosis of difficult conditions of unknown cause, including muscle and joint swelling and pain, fever and rash. Liu Meng, female, resident physician, master's degree in medicine, graduated from the Internal Medicine (Rheumatology and Immunology) program of Sun Yat-sen Medical University. Her main research direction is rheumatoid arthritis, and she specializes in the treatment of connective tissue diseases, including rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus and gout. She has participated in 1 Guangdong Provincial Natural Science Foundation project, published 2 papers in Chinese core journals, and published multiple abstracts at major international medical conferences, including EULAR and APLAR. Wang Yunqing, female, resident physician, master's degree in medicine, graduated from Qilu Hospital of Shandong University, and specializes in the diagnosis and treatment of rheumatic diseases, including rheumatoid arthritis, ankylosing spondylitis and systemic lupus erythematosus. She has participated in 1 Shandong Provincial Natural Science Foundation project, 1 research project of the Department of International Cooperation and Exchange of the Ministry of Education, and 1 Shenzhen Knowledge Innovation Program project. Li Xumian, female, resident physician, master's degree in medicine, graduated from the Internal Medicine program of Peking University and obtained a master's-level medical education and degree. During her 3 years as a master's student, she participated as the primary experimental operator in experiments related to a project under the National Major Scientific Instruments and Equipment Development Special Project. She specializes in experimental techniques including flow cytometry, real-time quantitative PCR and genetic testing, and is familiar with and proficient in their experimental principles. She has participated in domestic and international academic conferences on multiple occasions and has published 1 paper in an SCI journal (impact factor IF=2.9). She is proficient in the diagnosis and treatment of common rheumatic and immune diseases.